| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
| BH | base hospital; benzalkonium and heparin; bill of health; birth history; Bishop-Harman [instruments];... |
|---|---|
| CH | case history; Chediak-Higashi [syndrome]; chiasma; Chinese hamster; chloral hydrate; cholesterol; Ch... |
| GBH | gamma-benzene hexachloride; graphite benzalkonium-heparin |
| HAREM | heparin assay rapid easy method |
| HARM | heparin assay rapid method |
| LEO | Low Earth Orbit |
|---|---|
| LMW heparin | Low Molecular Weight heparin |
| HEP | 1--heparin |
| HSPG | heparin sulfate proteoglycan |
| H | Heparin |
| Buerger, Leo | <person> Austrian-U.S. Physician, 1879-1943. See: Winiwarter-Buerger disease, Buerger's disease. (05 Mar 2000) |
|---|---|
| Eloesser, Leo | <person> U.S. Thoracic surgeon, 1881-1976. See: Eloesser procedure. (05 Mar 2000) |
| Kanner, Leo | <person> Austrian psychiatrist in U.S., *1894. See: Kanner's syndrome. (05 Mar 2000) |
| Zambusch, Leo von | <person> 20th century German physician. See: generalised pustular psoriasis of Zambusch. (05 Mar 2000) |
| leo | <astronomy> 1. The Lion, the fifth sign of the zodiac, marked thus in almanacs. 2. A northern constellation east of Cancer, containing the bright star Regulus at the end of the handle of the Sickle. Leo Minor, a small constellation between Leo and the Great Bear. Origin: L. See Lion. Source: Websters Dictionary (01 Mar 1998) |
| Liebermann, Leo von | <person> Hungarian physician, 1852-1926. See: Burchard-Liebermann reaction, Liebermann-Burchard test. (05 Mar 2000) |
| Loeb, Leo | <person> U.S. Pathologist, 1869-1959. See: Loeb's deciduoma. (05 Mar 2000) |
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|